You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GC2129A

Showing 1 - 25 of 4,172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Seoul (GC2129A(Period 1), Linaglptin 5mg and Metformin Hydrocholoride 1000mg(Period 1),

Recruiting
  • Healthy Volunteers
  • GC2129A(Period 1)
  • +3 more
  • Seoul, Korea, Republic of
    H Plus YangJi Hospital
Feb 6, 2023

Healthy Volunteers Trial in Seoul (GC2129A(Period 1), Linaglptin 5mg and Metformin Hydrocholoride 1000mg(Period 1),

Recruiting
  • Healthy Volunteers
  • GC2129A(Period 1)
  • +3 more
  • Seoul, Korea, Republic of
    H Plus YangJi Hospital
Jan 19, 2023

COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)

Active, not recruiting
  • COVID-19
  • +2 more
  • VB10.2129
  • VB10.2210
  • Bergen, Norway
  • +1 more
Jan 6, 2023

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Anthrax Trial in Yeongeon-dong (GC1109 or Placebo of GC1109)

Completed
  • Anthrax
  • GC1109 or Placebo of GC1109
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 2, 2023

Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +4 more
  • GC101 TIL
  • Beijing, China
    Beijing Cancer Hospital
Nov 7, 2023

BCG Vaccination Reaction, Tuberculosis Trial (GC3107, Intradermal BCG SSI inj.)

Completed
  • BCG Vaccination Reaction
  • Tuberculosis
  • GC3107
  • Intradermal BCG SSI inj.
  • Suwon, Korea, Republic of
  • +1 more
Oct 31, 2022

Hypertriglyceridemia, Familial Trial in Nanjing (GC304)

Not yet recruiting
  • Hypertriglyceridemia, Familial
  • GC304
  • Nanjing, China
    Affiliated Jinling Hospital, Medical School, Nanjing University
May 5, 2023

Hepatitis B Trial (Undiluted I.V.-Hepabig inj(GC5103), Diluted I.V.-Hepabig inj(GC5103))

Not yet recruiting
  • Hepatitis B
  • Undiluted I.V.-Hepabig inj(GC5103)
  • Diluted I.V.-Hepabig inj(GC5103)
  • (no location specified)
Jan 19, 2023

Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • ctDNA Blood Test
  • +8 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University
Feb 8, 2023

Adenocarcinoma of the Stomach Trial in Goyang (Anti-EGFR antibody in combination with weekly paclitaxel)

Recruiting
  • Adenocarcinoma of the Stomach
  • Anti-EGFR antibody in combination with weekly paclitaxel
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center
Nov 29, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Sanhe (GC007F)

Completed
  • B-cell Acute Lymphoblastic Leukemia
  • GC007F
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Apr 21, 2022

Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)

Not yet recruiting
  • Cervical Cancer
  • Game Changers for Cervical Cancer Prevention
  • (no location specified)
Aug 17, 2023

Spinal Muscular Atrophy Trial in Beijing, Shenyang, Suzhou (GC101)

Recruiting
  • Spinal Muscular Atrophy
  • GC101
  • Beijing, China
  • +3 more
Apr 22, 2023

SMA II Trial in China (GC101)

Not yet recruiting
  • SMA II
  • GC101
  • Beijing, China
  • +4 more
Jun 15, 2023

Renal Impairment Trial in Miami (GC4419)

Completed
  • Renal Impairment
  • Miami, Florida
  • +1 more
Jun 7, 2022

Post-COVID Condition Trial in Zaragoza (Active nutrititional supplement, Placebo nutrititional supplement)

Active, not recruiting
  • Post-COVID Condition
  • Active nutrititional supplement
  • Placebo nutrititional supplement
  • Zaragoza, Spain
    IIS Aragón
Sep 27, 2023

Mucopolysaccharidosis II, Hunter Syndrome Trial in Pusan, Seoul (GC1123)

Not yet recruiting
  • Mucopolysaccharidosis II
  • Hunter Syndrome
  • GC1123
  • Pusan, Korea, Republic of
  • +2 more
Jun 16, 2022

Prognostic Model of GC/CTX in the Treatment of MN

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • glucocorticoid + cytoxan
  • (no location specified)
Dec 28, 2022

Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • glucocorticoid + tacrolimus
  • (no location specified)
Dec 28, 2022

Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Apr 7, 2023

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • (no location specified)
Sep 3, 2023

Covid19, SARS-CoV-2 Infection Trial in Iowa City, Saint Louis (GC4419, Placebo)

Terminated
Has Results
  • Covid19
  • SARS-CoV-2 Infection
  • Iowa City, Iowa
  • +2 more
Mar 14, 2022

Social Anxiety Disorder Trial in New York (GC-MRT, modified GC-MRT, Non-GC-MRT)

Suspended
  • Social Anxiety Disorder
  • GC-MRT
  • +2 more
  • New York, New York
    New York State Psychiatric Institute
Jan 6, 2022

Vitamin D Deficiency Trial in London (Vitamin D3 supplement)

Recruiting
  • Vitamin D Deficiency
  • Vitamin D3 supplement
  • London, Lobdon, United Kingdom
    St Mary's University Twickenham
Mar 24, 2023